Opthea (FRA:UKJ) Other Long-Term Liabilities : €62.57 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Opthea Other Long-Term Liabilities?

Opthea's other long-term liabilities for the quarter that ended in Dec. 2024 was €62.57 Mil.

Opthea's quarterly other long-term liabilities declined from Dec. 2023 (€165.77 Mil) to Jun. 2024 (€54.79 Mil) but then increased from Jun. 2024 (€54.79 Mil) to Dec. 2024 (€62.57 Mil).

Opthea's annual other long-term liabilities declined from Jun. 2022 (€-0.00 Mil) to Jun. 2023 (€-0.00 Mil) but then increased from Jun. 2023 (€-0.00 Mil) to Jun. 2024 (€54.79 Mil).

Opthea Other Long-Term Liabilities Historical Data

The historical data trend for Opthea's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opthea Other Long-Term Liabilities Chart

Opthea Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Long-Term Liabilities

Get a 7-Day Free Trial

54.79

Opthea Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long-Term Liabilities	Get a 7-Day Free Trial															83.06	-	165.77	54.79	62.57

Opthea Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Opthea Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Opthea's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Opthea Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (FRA:UKJ) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141

Website

https://www.opthea.com

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

Opthea Headlines

No Headlines